Finch Therapeutics Group, Inc.
FNCH
Revenue
0.00
0.000.00%
3 Months ChangeAssets
45.58M
▼-4.52M▼-9.02%
3 Months ChangeLiabilities
31.36M
▲303.00k▲0.9757%
3 Months ChangeFree Cash Flow
-4.36M
▲9.03M▲67.44%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 8-K
ID: 0001193125-24-240034
2024-08-13
Form 10-Q
ID: 0000950170-24-096246
2024-08-12
Form 8-K
ID: 0001193125-24-198362
2024-05-24
Form 8-K
ID: 0001193125-24-146454
2024-05-17
Form 8-K
ID: 0001193125-24-141816
2024-05-10
Form 10-Q
ID: 0000950170-24-057912
2024-04-03
Form 8-K
ID: 0001193125-24-085435
2024-02-23
Form 8-K
ID: 0001193125-24-044511
2023-11-17
Form 8-K
ID: 0001193125-23-279821
2023-11-08
Form 10-Q
ID: 0000950170-23-060651